Results 251 to 260 of about 222,436 (284)
Integrative in vitro and in silico evaluation of HSP60-derived peptides as immunomodulators of the TLR4/MD-2 complex. [PDF]
Vila-Casahonda RG +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
TLR4 biased small molecule modulators
Pharmacology & Therapeutics, 2021Biased pharmacological modulators provide potential therapeutic benefits, including greater pharmacodynamic specificity, increased efficiency and reduced adverse effects. Therefore, the identification of such modulators as drug candidates is highly desirable.
Lin, C. +8 more
openaire +3 more sources
Circ-TLR4 promotes cardiac hypertrophy through recruiting FUS to stabilize TLR4 mRNA
Journal of Interventional Cardiac Electrophysiology, 2022Cardiac hypertrophy is an adaptive and compensatory mechanism preserving cardiac output during detrimental stimuli. Circular RNAs (circRNAs) have been illustrated to exert important implications in the pathogenesis of multiple cardiovascular diseases (CVD) including demonstrated cardiac hypertrophy.
Chao Li +6 more
openaire +2 more sources
Science, 2013
Cytoplasmic lipopolysaccharide from Gram-negative bacteria can activate the innate immune system directly.
openaire +2 more sources
Cytoplasmic lipopolysaccharide from Gram-negative bacteria can activate the innate immune system directly.
openaire +2 more sources
TLR4 polymorphisms and disease susceptibility
Inflammation Research, 2012Toll-like receptors (TLRs) play a central role in the regulation of the host immune system. Each TLR recognizes specific pathogen-associated molecular patterns (PAMPs). TLR4 is one of the well characterized pathogen recognition receptors (PRRs) that recognizes the lipopolysaccharide (LPS) of Gram-negative bacteria, some conserved structures from fungal
Mamoona, Noreen +7 more
openaire +2 more sources

